Doctor profile · Federal record

Dr. Megan Bielawski, M.D.

Rheumatology Physician (CMS: Rheumatology) · Akron, OH

  • NPI 1073900080
  • Accepts Medicare
  • MIPS 93.0 / 100 · 2023
  • 11 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
471 N Cleveland Massillon RD
Akron, OH 443332426
(330) 668-4045
fax (330) 668-2492

Credentials & registration

NPPES · NUCC
NPI registered
April 2015 — 11 yrs on file
Profile last updated
May 8, 2020
Year of graduation
2015 — 11 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Ohio #35.138905

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1073900080. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
72,482
Distinct HCPCS
10
Medicare allowed
$1,013,211
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 31,200 12 $5
J3111 Injection, romosozumab-aqqg, 1 mg 13,230 11 $10
J1602 Injection, golimumab, 1 mg, for intravenous use 9,100 15 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 7,050 14 $42
J0897 Injection, denosumab, 1 mg 4,380 46 $23
J1745 Injection, infliximab, excludes biosimilar, 10 mg 1,350 11 $33
36415 Insertion of needle into vein for collection of blood sample 666 362 $8
82565 Blood creatinine level 548 303 $5
86140 Measurement c-reactive protein for detection of infection or inflammation 481 268 $5
85652 Red blood cell sedimentation rate, to detect inflammation, automated 476 266 $3

In context: peer comparison

Among 4 peers in Akron Rheumatology Physician, average services per provider: 1,161. This provider delivers 62× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,483
Transactions
152
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 39 $526.00
Amgen INC. 28 $436.71
Ucb, INC. 8 $258.45
E.R. Squibb & Sons, L.L.C. 16 $219.13
Janssen Biotech, INC. 9 $208.14
GlaxoSmithKline, LLC. 14 $200.16
Pfizer INC. 12 $164.31
Lilly USA, LLC 7 $109.13
AstraZeneca Pharmaceuticals Lp 5 $97.13
Radius Health, INC. 4 $76.80
Boehringer Ingelheim Pharmaceuticals, INC. 3 $54.47
Novartis Pharmaceuticals Corporation 3 $49.98
Sandoz INC. 2 $29.23
Organon LLC 1 $22.02
Fresenius Kabi USA, LLC 1 $15.95

By nature of payment

Food and Beverage
$2,483

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,219
Patients
712
Total drug cost
$945,129
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 645 194 $31,922
Methotrexate (Methotrexate Sodium) Brand 468 148 $20,411
Prednisone Generic 241 97 $2,842
Leflunomide Generic 214 62 $18,763
Sulfasalazine Dr (Sulfasalazine) Brand 133 47 $6,660
Alendronate Sodium Generic 125 44 $712
Allopurinol Generic 65 26 $596
Meloxicam Generic 62 28 $332
Leucovorin Calcium Generic 58 24 $809
Enbrel Sureclick (Etanercept) Brand 49 0 $414,418

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Megan Bielawski's medical specialty?
Dr. Megan Bielawski practices Rheumatology Physician in Akron, OH.
Where does Dr. Megan Bielawski practice?
Dr. Megan Bielawski practices at 471 N Cleveland Massillon RD, Akron, OH 443332426. Office phone: 3306684045.
What is Dr. Megan Bielawski's NPI?
Dr. Megan Bielawski's National Provider Identifier (NPI) is 1073900080, issued by NPPES.
Does Dr. Megan Bielawski accept Medicare assignment?
Yes. Dr. Megan Bielawski accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Megan Bielawski commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.